India refuses drugmakers requests to extend deadline for plant upgradation
- byDoctor News Daily Team
- 17 October, 2025
- 0 Comments
- 0 Mins

New Delhi: In a decisive move that has sparked both controversy and support, India has rejected requests from drugmakers to extend the year-end deadline for upgrading their manufacturing facilities to international standards. The decision comes amid public outrage over the recent deaths of at least 24 children linked to a locally produced cough syrup, reigniting serious concerns about drug safety and regulatory oversight.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Mumbai's GT Hospital doctor injured after ceiling...
- 20 October, 2025
Rajasthan HC Quashes Ban on New B.Pharm Colleges,...
- 20 October, 2025
Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufactu...
- 20 October, 2025
CDSCO Panel Rejects Pure and Cure's Empagliflozin-...
- 20 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!